2 Medications reviewed included: semaglutide, dulaglutide, tirzepatide, lixisenatide, liraglutide, and exenatide
To align costs and evidence, CVS standard template formularies (as of Feb 2024) made Wegovy and Saxenda its preferred agents among GLP-1s for obesity, relegating other anti-obesity drugs (Qsymia, orlistat, phentermine, etc.) to lower tiers ( [41] )
Rights and permissions About this article Cite this article Angel, C.Z., Iguacel, I., Mullee, A
The generated tubuloids showed active transepithelial transport function and were used to model several diseases, including BK virus, Wilms tumor, and cystic fibrosis, showing the great potential of this culture system for disease modeling and the possibility to use it for drug screening (Schutgens et al